Table I.
Control | TRAIL | HIV | TRAIL ± HIV | |
---|---|---|---|---|
TRAIL R1 | 54.91 ± 9.15 | 54.12 ± 6.65 | 50.37 ± 7.548 | 50.25 ± 8.51 |
TRAIL R2 | 59.9 ± 17.1 | 58.62 ± 15.56 | 56.12 ± 18.36 | 61.28 ± 13.48 |
TRAIL R3 | 48.82 ± 10.88 | 39.68 ± 8.11 | 42.86 ± 7.73 | 55.53 ± 15.13 |
TRAIL R4 | 64.99 ± 18.38 | 50.7 ± 11.59 | 51.7 ± 11.34 | 38.91 ± 7.4 |
Data are mean fluorescent intensities ± SEM of different TRAIL receptors assessed by FACS (see Fig. 4). Data analyzed by ANOVA showed no statistically significant differences between any of the treatment groups for any TRAIL receptors.